Methylphenidate ER 36 mg tablet: Supply issue resolved

Teva have advised that they have released supplies of methylphenidate ER 36 mg tabs (pharmacode 2562782) to wholesalers.

Affected product

Only the 36 mg tablets (pharmacode 2562782) of Teva's Methylphenidate ER was affected by this issue. All other presentations (including the 18 mg tablet) remained available. 

Schedule listing for methylphenidate(external link)

There are no supply issues with methylphenidate immediate-release, sustained-release, modified-release or the Concerta brand of extended-release

NZ Formulary monograph for methylphenidate(external link)

Expected resupply date

Teva advises that they supply had resumed by early July 2022.

Who to contact

If you have questions about the availability of this medicine, contact Teva Pharmaceuticals(external link)

If you have questions about the funding of this medicine, email